Erlotinib 150mg Tablet (Erlocip) :
Erlotinib 150mg tablet Anti Cancer medicine is used in the treatment of non-small cell lung cancer and pancreatic cancer. It should be taken in a dose as recommended by the doctor. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment.
Your doctor may advise for regular monitoring of liver function while you’re taking this medicine. It is advisable to avoid smoking while taking Erlocip 150 Tablet as it makes the medicine ineffective and requires dose adjustment. Women who are undergoing treatment should use effective contraception methods. It is important to avoid pregnancy during the treatment and for a month after completing the course of medicine.
This medicine may make your skin more sensitive to the sun, so it is better to use sunscreen and protective clothing when outdoors. Diarrhea may occur as its side effects, so drink plenty of fluids. But, you must inform the doctor if it does not stop or you find blood in stools. In case you develop ulceration in the mouth, changes in your vision, or breathing difficulties then it is better to inform the doctor.
USES OF ERLOCIP TABLET :
- Non-small cell lung cancer
- Pancreatic cancer
SIDE EFFECTS OF ERLOCIP TABLET :
- Abdominal pain
- Edema (swelling)
- Weight loss
- Bone pain
- Stomatitis (Inflammation of the mouth)
- Shortness of breath
- Muscle pain
HOW TO USE ERLOCIP TABLET :
Take this tablet in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Erlocip medicine is to be taken empty stomach.
HOW ERLOCIP TABLET WORKS :
Erlocip 150 Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. These tablets work by binding the chemical messenger, EGFR, hence, inhibits the cancer signalling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells.
Erlotinib 150 mg tablet
To Read More From Us = Click Here
To Visit Our Second Site = Click Here